Objective To explore the effects of resveratrol (RSV) on regulating the apoptosis, invasion ability and epithelial-meshenchymal transition (EMT) of GBC-SD cells and the underlying mechanisms.
Methods GBC-SD cells were cultured in vitro, and randomly divided into blank group, RSV low, medium and high dose groups (0, 20, 50, 100 μmol·L-1 RSV). Annexin V-FITC/PI double stain flow cytometry was used to analyze the cellular apoptosis, RT-PCR assay was used to test the mRNA expression level of Bcl-2, Bax and Caspase 3, Transwell invasion assay was used to test the invasion ability of GBC-SD cells, and Western blotting assay was used to detect the protein expression of EMT markers (E-cadherin, N-cadherin and Vimentin) and Hedgehog signaling members (Gli1, Gli2 and Shh). GBC-SD cells were then randomly divided into blank plasmid group, Gli1 overexpression plasmid group, and Gli1 overexpression plasmid+RSV group. The overexpression of Gli1 protein was detected by Western blotting, and the apoptosis rate and invasion ability were detected in the above group by Annexin V-FITC/PI double stain flow cytometry and transwell invasion assay respectively.
Results Compared with the blank group, the apoptosis rate, Bax and Caspase 3 mRNA expression in each RSV dose group were significantly increased (P<0.05 or P<0.01), and the cell invasion ability was significantly reduced (P<0.01); the expression of Bcl-2 mRNA in the middle and high dose groups of RSV significantly decreased (P<0.01). Compared to the blank group, the protein expression level of E-cadherin was significantly increased, while the protein expression level of N-cadherin, Vimentin, Gli1, Gli2 and Shh were significantly decreased in the high-dose group of RSV (P<0.01). Compared with the transfected empty plasmid+RSV group, the apoptosis rate of cells in the Gli1 overexpression plasmid+RSV group was reduced and the invasion ability was increased (P<0.001).
Conclusion RSV promotes GBC-SD cell apoptosis, inhibits GBC-SD cell invasion and EMT, and its mechanism of action may be related to the inhibition of Hedgehog signaling.
1.Sharma A, Sharma KL, Gupta A, et al. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update[J]. World J Gastroenterol, 2017, 23(22): 3978-3998. DOI: 10.3748/wjg.v23.i22.3978.
2.Matsushita S, Onishi H, Nakano K, et al. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer[J]. Cancer Sci, 2014, 105(3): 272-280. DOI: 10.1111/cas.12354.
3.Rauf A, Imran M, Butt MS, et al. Resveratrol as an anti-cancer agent: a review[J]. Crit Rev Food Sci Nutr, 2018, 58(9): 1428-1447. DOI: 10.1080/10408398. 2016.1263597.
4.张文兴, 李嘉懿. 白藜芦醇白蛋白纳米粒对人胆囊癌GBC-SD细胞凋亡的影响[J]. 中医肿瘤杂志, 2019, 1(4): 45-48. [Zhang WX, Li JY. Effect of resveratrol bovine serum albumin nanoparticles on apoptosis of human gallbladder carcinoma GBCSD cells[J]. Journal of Oncology in Chinese Medicine, 2019, 1(4): 45-48. DOI: 10.19811/j.cnki.issn2096-6628.2019.04.010.
5.胜利, 安利峰, 何烨, 等.白藜芦醇抑制胆囊癌细胞生长与诱导细胞凋亡的实验研究[J]. 中药材, 2005, 28(6): 489-491. [Sheng L, An LF, He Y, et al. Experimental study on inhibiting growth and inducing apoptosis of gallbladder carcinoma cells by resveratrol[J]. Journal of Chinese Medicinal Materials, 2005, 28(6): 489-491. DOI: 10.13863/j.issn1001-4454.2005.06.020.
6.Mo WH, Xu XF, Xu L, et al. Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell[J]. Pancreatology, 2011, 11(6): 601-609. DOI: 10.1159/000333542.
7.Gao Q, Yuan Y, Gan HZ, et al. Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis[J]. Oncol Lett, 2015, 9(5): 2381-2387. DOI: 10.3892/ol.2015.2988.
8.Ferraresi A, Esposito A, Girone G, et al. Resveratrol contrasts LPA-induced ovarian cancer cell migration and platinum resistance by rescuing hedgehog-mediated autophagy[J]. Cells, 2021, 10(11): 3213-3213. DOI: 10.3390/CELLS10113213.
9.Guo K, Feng YQ, Zheng XE, et al. Resveratrol and its analogs: potent agents to reverse epithelial-to-mesenchymal transition in tumors[J]. Front Oncol, 2021, 11: 644134. DOI: 10.3389/FONC.2021.644134.
10.Yin BB, Wu SJ, Zong HJ, et al. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD[J]. J Zhejiang Univ Sci B, 2011, 12(4): 256-263. DOI: 10.1631/jzus.B1000303.
11.Chen HP, Wu XJ, Duan YT, et al. Ursolic acid isolated from Isodon excisoides induces apoptosis and inhibits invasion of GBC-SD gallbladder carcinoma cells[J]. Oncol Lett, 2019, 18(2): 1467-1474. DOI: 10.3892/ol.2019. 10397.
12.Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors[J]. Int J Cancer, 2006, 118(7): 1591-1602. DOI: 10.1002/ijc.21683.
13.Bal MM, Ramadwar M, Deodhar K, et al. Pathology of gallbladder carcinoma: current understanding and new perspectives[J]. Pathol Oncol Res, 2015, 21(3): 509-525. DOI: 10.1007/s12253-014-9886-3.
14.Roncoroni L, Elli L, Braidotti P, et al. Transglutaminase 2 mediates the cytotoxicity of resveratrol in a human cholangiocarcinoma and gallbladder cancer cell lines[J]. Nutr Cancer, 2018, 70(5): 761-769. DOI: 10.1080/01635581.2018.1470648.
15.Xu SW, Zhan M, Wang J. Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks[J]. Cell Death Discov, 2017, 3: 17069. DOI: 10.1038/cddiscovery.2017.69.
16.Xie F, Xu XP, Xu AG, et al. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma[J]. Hum Pathol, 2014, 45(3): 513-521. DOI: 10.1016/j.humpath.2013.10.017.
17.Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition[J]. Sci Signal, 2014, 7(344): re8. DOI: 10.1126/scisignal.2005189.
18.Liu XF, Wang K, Du HC. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p[J]. Eur Rev Med Pharmacol Sci, 2020, 24(14): 7598-7611 .DOI: 10.26355/eurrev_ 202007_22258.
19.Tian L, Deng ZD, Xu L, et al. Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-iota/GLI1 pathway[J]. Cell Death Dis, 2018, 9(11): 1115. DOI: 10.1038/s41419-018-1145-1.